These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 2027674)
1. [Therapeutic possibilities in the treatment of the myelodysplasia syndrome]. Bozóky G; Biliczki F Orv Hetil; 1991 May; 132(19):1011-5. PubMed ID: 2027674 [TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR; Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337 [TBL] [Abstract][Full Text] [Related]
4. [Myelodysplastic syndromes]. Geissler K Wien Med Wochenschr; 1991; 141(9-10):201-4. PubMed ID: 1949844 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648 [TBL] [Abstract][Full Text] [Related]
7. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification]. Piguet D; Schmidt PM; Delacrétaz F; Mermillod B Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610 [TBL] [Abstract][Full Text] [Related]
8. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience. Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902 [TBL] [Abstract][Full Text] [Related]
12. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes]. García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic and autologous stem cell transplantation in myelodysplastic syndromes. De Witte T Pathol Biol (Paris); 1997 Oct; 45(8):643-9. PubMed ID: 9569930 [TBL] [Abstract][Full Text] [Related]